USFDA approved Zydus for baclofen tablets

The US Food and Drug Administration (FDA) approved Zydus Cadila to market baclofen tablets, 5 mg.

Baclofen is used to treat muscle spasms caused by certain conditions like multiple sclerosis, spinal cord injury/disease. Baclofen helps in relaxing the muscles. It will be manufactured at the group’s formulations manufacturing facility at Baddi.

  • Related Posts

    Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge

    Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Senores Pharma to Buy Two Teva ANDAs

    Senores Pharma to Buy Two Teva ANDAs

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lilly launches Mounjaro KwikPen in India

    Lilly launches Mounjaro KwikPen in India